penicillin g has been researched along with bekanamycin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Li, HQ; Lv, PC; Shi, L; Xue, JY; Zhu, HL | 1 |
| Fang, RQ; Li, HQ; Liu, CH; Lv, PC; Xiao, ZP; Zhu, HL | 1 |
| Li, HQ; Lv, PC; Ma, GY; Song, ZC; Xiao, ZP; Zhu, HL | 1 |
| Chen, J; Lv, PC; Mao, WJ; Wang, KR; Xiong, J; Yang, Y; Zhu, HL | 1 |
| Li, HQ; Liu, CH; Luo, Y; Lv, PC; Shi, L; Zhu, HL | 1 |
| Luo, Y; Lv, PC; Sun, J; Yang, Y; Zhu, HL | 1 |
| Liu, K; Qin, X; Wang, XM; Zhang, HJ; Zhu, DD; Zhu, HL | 1 |
| Cheng, K; Xue, JY; Zhu, HL | 1 |
| Makawana, JA; Sun, J; Zhu, HL | 1 |
| Dong, JJ; Du, QR; Fang, F; Li, DD; Li, JR; Sun, J; Wang, RR; Zhang, WM; Zhu, HL | 1 |
| Lin, L; Makawana, JA; Sangani, CB; Teraiya, SB; Zhang, X; Zhu, HL | 1 |
| Beteck, RM; Jesumoroti, OJ; Legoabe, LJ; Patel, OPS | 1 |
| Inagaki, M; Majima, Y; Mitsui, H; Miyoshi, Y; Sakakura, Y | 1 |
1 review(s) available for penicillin g and bekanamycin
| Article | Year |
|---|---|
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiprotozoal Agents; Drug Development; Humans; Hypoglycemic Agents; Metronidazole | 2021 |
12 other study(ies) available for penicillin g and bekanamycin
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Escherichia coli; Luteolin; Microbial Sensitivity Tests; Pseudomonas fluorescens; Spectrum Analysis; Staphylococcus aureus; Structure-Activity Relationship | 2009 |
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
Topics: Anti-Bacterial Agents; Bacteria; Crystallography, X-Ray; Depsides; Drug Design; Microbial Sensitivity Tests; Structure-Activity Relationship | 2009 |
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Bacteria; Crystallography, X-Ray; Inhibitory Concentration 50; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thiazolidines | 2009 |
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Anti-Bacterial Agents; Drug Design; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Stereoisomerism; Thiazoles | 2009 |
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
Topics: Anti-Inflammatory Agents; Bacterial Proteins; Benzoin; Drug Design; Enzyme-Linked Immunosorbent Assay; Models, Molecular | 2010 |
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Anti-Bacterial Agents; Binding Sites; Computer Simulation; Drug Design; Enzyme Inhibitors; Escherichia coli Proteins; Pyrazoles; Structure-Activity Relationship | 2010 |
Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Crystallography, X-Ray; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pseudomonas aeruginosa; Schiff Bases; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Thiourea | 2011 |
Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Anti-Bacterial Agents; Bacillus subtilis; Binding Sites; Drug Design; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Structure, Tertiary; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 2013 |
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; ErbB Receptors; Humans; Microbial Sensitivity Tests; Models, Molecular; Nitroimidazoles; Protein Kinase Inhibitors; Schiff Bases; Structure-Activity Relationship; Thermodynamics | 2013 |
Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Acetyltransferases; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fatty Acid Synthase, Type II; Humans; Molecular Docking Simulation; Structure-Activity Relationship; Thiazoles | 2014 |
Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Docking Simulation; Pyrazoles; Pyridines; Quinolines; Structure-Activity Relationship | 2014 |
Absorption of various drugs through the rabbit's respiratory mucosa in vitro.
Topics: Absorption; Animals; Cefazolin; Doxycycline; Immunoenzyme Techniques; Immunoglobulin G; Kanamycin; Mucous Membrane; Nasal Mucosa; Penicillin G; Pharmaceutical Preparations; Prednisolone; Rabbits; Respiratory System | 1983 |